Pharmacogenetics of Response to GLP1R Agonists
Latest Information Update: 05 Aug 2022
At a glance
- Drugs Semaglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms PORT
- 29 Jul 2022 Status changed from not yet recruiting to recruiting.
- 16 May 2022 Planned initiation date changed from 15 Apr 2022 to 1 Jun 2022.
- 15 Mar 2022 Planned initiation date changed from 1 Mar 2022 to 15 Apr 2022.